NCT05233813 is a NA clinical trial of Active Body and Mind in Well Aging, sponsored by University of Michigan.

Who is sponsoring NCT05233813?

NCT05233813 is sponsored by University of Michigan.

What drugs are being tested in NCT05233813?

Interventions in NCT05233813: Active Body and Mind.

What condition does NCT05233813 study?

NCT05233813 studies Well Aging.

Is NCT05233813 still recruiting?

NCT05233813 is currently completed. Last updated 10 February 2022.

Last reviewed 2022-02-10 · How we verify

NCT05233813

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Active Body and Mind Intervention for Older Adults

Completed NA Last updated 10 February 2022

What this trial tests

NA trial testing Active Body and Mind in Well Aging in 59 participants. Completed in 6 December 2019.

Timeline

13 September 2019

Primary endpoint
6 December 2019

6 December 2019

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	59
Start date	13 September 2019
Primary completion	6 December 2019
Estimated completion	6 December 2019
Sites	1 location across United States

Drugs / interventions tested

Active Body and Mind

Conditions studied

Well Aging — all drugs for Well Aging →

Sponsor

University of Michigan

Who can join

65 and older, any sex, with Well Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to examine the effectiveness and acceptability of wearable activity trackers with self-regulatory techniques for promoting physical activity (PA) in older adults. In addition, this study aimed to investigate the impact of a multicomponent PA intervention on life satisfaction, happiness, eudaimonic well-being, and depressive symptoms, reflecting different dimensions of psychological well-being, in older adults.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy and acceptability of using wearable activity trackers in older adults living in retirement communities: a mixed method study.
Zhang Z, Giordani B, Margulis A, Chen W. · · 2022 · cited 19× · PMID 35313819 · DOI 10.1186/s12877-022-02931-w

Verify or expand the search:

Other University of Michigan trials

Trials by the same sponsor.

NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05233813 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 10 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05233813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing